LETO, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 7.063
EU - Europa 3.966
AS - Asia 3.374
SA - Sud America 477
AF - Africa 116
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.009
Nazione #
US - Stati Uniti d'America 6.941
SG - Singapore 1.253
RU - Federazione Russa 1.036
CN - Cina 878
IT - Italia 816
FI - Finlandia 447
BR - Brasile 381
DE - Germania 338
HK - Hong Kong 325
UA - Ucraina 305
VN - Vietnam 300
PL - Polonia 220
GB - Regno Unito 184
FR - Francia 174
IE - Irlanda 146
JP - Giappone 140
SE - Svezia 103
IN - India 98
BD - Bangladesh 69
CA - Canada 62
KR - Corea 61
TR - Turchia 43
EG - Egitto 39
AR - Argentina 34
BE - Belgio 30
IQ - Iraq 30
RO - Romania 30
ES - Italia 28
MX - Messico 28
NL - Olanda 25
IR - Iran 24
CI - Costa d'Avorio 21
AT - Austria 19
UZ - Uzbekistan 17
ZA - Sudafrica 17
NP - Nepal 15
VE - Venezuela 15
MY - Malesia 14
PK - Pakistan 14
CZ - Repubblica Ceca 13
CL - Cile 12
MA - Marocco 12
PH - Filippine 12
SA - Arabia Saudita 11
CH - Svizzera 9
EC - Ecuador 9
ID - Indonesia 9
JM - Giamaica 9
JO - Giordania 9
LT - Lituania 9
AU - Australia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CO - Colombia 7
KE - Kenya 7
KZ - Kazakistan 7
TW - Taiwan 7
BO - Bolivia 6
DZ - Algeria 6
PA - Panama 6
PT - Portogallo 5
PY - Paraguay 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
ET - Etiopia 4
GR - Grecia 4
IL - Israele 4
LB - Libano 4
RS - Serbia 4
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
SV - El Salvador 3
TN - Tunisia 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
BS - Bahamas 2
HU - Ungheria 2
NO - Norvegia 2
PE - Perù 2
SN - Senegal 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
CG - Congo 1
CY - Cipro 1
GM - Gambi 1
GP - Guadalupe 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 15.001
Città #
Singapore 872
Ashburn 843
Chandler 573
Fairfield 523
San Jose 474
Woodbridge 352
Hong Kong 304
Ann Arbor 270
Dallas 268
Wilmington 262
Houston 241
Palermo 237
Seattle 207
Cambridge 202
Moscow 193
Zgierz 171
Jacksonville 156
Beijing 150
Dublin 146
Tokyo 131
Medford 128
New York 120
Frankfurt am Main 107
Des Moines 106
Santa Clara 105
Council Bluffs 103
Los Angeles 100
Ho Chi Minh City 98
Princeton 84
Lauterbourg 80
Boardman 79
The Dalles 78
Hanoi 72
Altamura 68
Nanjing 60
Helsinki 57
Lawrence 54
Buffalo 50
San Diego 50
Milan 48
Jinan 44
Hefei 43
Tulsa 41
São Paulo 38
Orem 36
Tianjin 32
Shenyang 31
Brussels 30
Nanchang 30
Chicago 29
Chennai 28
Dearborn 26
Guangzhou 26
London 26
Munich 26
Changsha 25
Atlanta 23
Ludwigshafen am Rhein 23
Hebei 22
Warsaw 22
Abidjan 21
Montreal 21
Cairo 20
Rome 19
Columbus 18
Denver 18
Naples 17
Phoenix 17
Turku 17
Seoul 16
Haiphong 15
Stockholm 15
Jiaxing 14
Johannesburg 14
Ningbo 14
Washington 14
Zhengzhou 14
Da Nang 13
Kumar 13
Manchester 13
Poplar 13
Izmir 12
Mumbai 12
Rio de Janeiro 12
Saint Petersburg 12
Tashkent 12
Amsterdam 11
Ankara 11
Brooklyn 11
Cardiff 11
City of London 11
Istanbul 11
Bagheria 10
Boston 10
Lublin 10
Shanghai 10
Tehran 10
Toronto 10
Amman 9
Auburn Hills 9
Totale 9.363
Nome #
Effects of Oleuropein on colon cancer progression in vitro. A preliminary report 390
Cathepsin L in metastatic bone disease: therapeutic implications 325
3,5-DIIODO-L-THYRONINE-INDUCED MODIFICATION IN PITUITARY-THYROID AXIS IN RATS FED HIGH-FAT DIET. A PRELIMINARY REPORT 318
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer 306
Different Behaviour of Plasma Antioxidant Status after Red Wine Consumption in Subjects of the Same Sex: A Preliminary Report 278
Vitamin D in cancer chemoprevention 276
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications 275
Follistatin as potential therapeutic target in prostate cancer 271
Effects of 3,5-diiodo-L-thyronine on the liver of high fat diet fed rats 269
Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications 266
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse 266
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 264
Influence of quercetin and luteolin on the activity of the catalase: study ex vivo about erythrocytes in smokers and non-smokers 259
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. 252
Flavonols and flavan-3-ols as modulators of xanthine oxidase and manganese superoxide dismutase activity 232
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report 225
Cathepsin L in normal and pathological bone reodeling 224
Serum follistatin in patients with prostate cancer metastatic to the bone 210
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 207
Effects of extra virgin olive oil phenols on HL60 cell lines sensitive and resistant to anthracycline 200
Activin A and bone metastasis 200
The Role of Vitamin K in Bone Remodeling and Osteoporosis 200
Activin A and matrix metalloproteinase -2 and -9 blood levels as gauges of bone metastatic spread 198
ACTIVIN A CIRCULATING LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS OR BONE METASTASES FROM BREAST CANCER 198
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. 197
On the role of cystatin C in cancer progression 197
Activin A circulating levels in patients with osteoporosis or bone metastasis from breast cancer 196
Current status and future directions in the treatment of bone metastases from breast cancer 194
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma 194
Effects of extra virgin olive oil phenols on HL60 cell lines sensitive and resistant to anthracyclines 192
Effect of extra virgin olive oli phenols on HL60 cell lines sensitive and resistant to anthracyclines 192
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications 192
Adipokines in obesity and metabolic diseases 191
Induction of differentiation by phenols crude extract of extravirgin olive oil on tumor cell lines sensitive and resistatnt to antitumor agents 185
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression 183
Effects of oleuropein on tumor cell growth and bone remodelling: Potential clinical implications for the prevention and treatment of malignant bone diseases 183
Activin A circulating levels in Patients with primary osteoporosis or bone metastases from brest cancer 181
Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis. 181
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma 180
ERYTHROCYTE CATALASE ACTIVITY IN EVER-SMOKERS AND NO-SMOKERS HEALTHY SUBJECTS: INFLUENCE OF FLAVONOIDS (QUERCETIN AND LUTEOLIN) 180
Cytotoxic effects of a crude extract of extra virgin olive oil on human HL60 cell lines sensitive and resistant with MDR phenotype 177
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 176
Studio del pattern di distribuzione dell'Activina A nel siero di pazienti con metastasi ossee da carcinoma prostatico in trattamento con acido zoledronico 174
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 172
Cytotoxic effects of polyphenols from waste-water of extra virgin olive oil on human HL60 and K562 cell lines. 171
Haemopoietic effects of 7 alpha, 17 beta Dimethyltestosterone 165
Effects of phenols of extra virgin olive oil on HL60 cell lines sensitive and reristant to anthracyclines 160
Activin a and matrix metalloproteinase-2 and -9 blood levels as gauges of bone metastatic spread. In: Tumor microenvironment:Heterotypic interactions. 160
Bioactive effects of citrus flavonoids and role in the prevention of atherosclerosis and cancer 157
Cathepsin D in the malignant progression of neoplastic diseases 157
Cathepsin D content in colorectal cancer 155
Nutrition, obesity and hormones 154
Effects of phenols of extra vergin olive oil on Hl60 cell lines sensitive and resistant to anthracycline 153
Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters 150
Effects of E-64 (cysteine-proteinase inhibitor) and Pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors 150
Modulating activity of dietary flavonols and flavan-3ols on the enzymes xanthina oxidase (XO) and mitochondrial superoxide dismutase (Mn-SOD) 146
Acute myocardial effects of mitoxantrone in the rabbit 146
Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A 146
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. 144
Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical Implications 141
Cathepsin D: A possible biochemical marker for anthracycline cardiomyopathy 139
Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice 138
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma 137
Lysosomal alterations in heart and liver of mice treated with doxorubicin 137
The potential of cystatin C as a predictive biomarker in breast cancer 135
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis 134
Influence of flavonoids on the transmembrane electron transport:study ex-vivo 133
Effects of amsacrine (m-AMSA) a new aminoacridine antitumor drug, on the rabbit heart 131
Zoledronic acid-induced variations in MMP-2, MMP-9 and uPA plasma concentrations in patients with metastatic bone disease 129
Clinical significance of Activin A serum levels in patients with primary osteoporosis: a preliminary report 128
Induction of differentiation by phenols crude extract of extavirgin olive oil on tumor cell lines sensitive and resistant to anticancer drugs 126
Effects of extra virgin olive oil phenols on HL60 cell lines sensitve and resistant to anthracycline 125
Effects of eztra virgin olive oil phenols on HL60 cell line sensitive and resistant to anthracycline. 125
Selenium and Autoimmune Thyroiditis 122
Biological characterization of laryngeal squamous-cell carcinoma 122
Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance 120
Physyological role of t-PMET in erythrocytes redox homeostasis: influence of flavonoids 111
Stefin A and cathepsin B and L circulating serum levels in patients with malignant or non-malignant liver diseases: A preliminary report 107
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 95
LIVELLI CIRCOLANTI DI ACTIVINA A IN PAZIENTI CON OSTEOPOROSI PRIMITIVA O METASTASI OSSEE DA CARCINOMA MAMMARIO 95
Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis 95
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes 94
Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications 90
Characterization of the metastatic properties of two methylcholantrene-induced fibrosarcoma in mice 84
Tumor markers in urogynaecological tumors. 72
Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells 72
null 59
null 47
null 3
Totale 15.386
Categoria #
all - tutte 49.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.026 50 230 9 47 40 39 41 55 140 150 41 184
2022/20231.432 150 238 53 176 130 257 84 111 143 11 45 34
2023/2024722 34 96 49 55 63 119 56 65 21 36 33 95
2024/20251.648 36 79 98 194 74 74 113 116 98 179 240 347
2025/20266.070 466 147 500 500 597 909 829 559 435 708 201 219
2026/2027166 166 0 0 0 0 0 0 0 0 0 0 0
Totale 15.386